The revolutionary medical discoveries developed from our research institutes and Memory and Movement Care Centers of Excellence are successful in part because of the spirited nature of our partnerships and collaborations. We turn ideas and hypotheses into scientific innovations that change the future of medicine, impacting millions of people globally. Contact us today to learn how your organization can collaborate with Banner Research.
Setting the standard for Alzheimer’s disease research collaboration at the state level, the Arizona Alzheimer’s Consortium’s mission is to search for new and promising approaches for the detection, treatment and prevention of Alzheimer’s disease - without losing another generation. Founded in 1998, the consortium leverages its member institutions’ strengths in neuroscience, brain imaging, genomics, computer science and clinical and neuropathology research to foster solidarity with an eye toward advancing the understanding of Alzheimer’s, and discover new treatments that prevent and cure Alzheimer’s. Furthermore, the consortium strives to educate Arizona communities about the medical advancements being made with Alzheimer’s research, as well as the resources available to families, patients and professionals so they can effectively manage the disease.
Banner Alzheimer’s Institute and Banner Sun Health Research Institute (BSHRI) are among 33 medical centers in the United States that are designated Alzheimer's Disease Research Centers (ADRCs). These centers receive grant funds from the National Institute on Aging (NIA) to focus on improving the diagnosis and care for those affected by Alzheimer’s disease as well find a treatment or way to prevent Alzheimer's and other dementia-related diseases. As part of a recognized Arizona Alzheimer’s Disease Research Center, Alzheimer’s Institute and Banner Sun Health Research Institute offer patients at Banner Health the chance to participate in Alzheimer’s clinical trials and prevention studies, access to support groups and programs and assistance with getting a diagnosis and the care that follows.
Founded in 1998, the mission of the Alzheimer's Drug Discovery Foundation is to rapidly accelerate the discovery of treatments to prevent, treat and cure Alzheimer's disease. The foundation is the only charity solely focused on finding treatments for Alzheimer’s through the funding of preclinical treatment discovery and early-stage clinical trials for potential treatment targets - enabling leading scientists to pursue pioneering ideas to cure Alzheimer’s disease that would otherwise be unexplored.
The Alzheimer’s Association has forged a workgroup of experts from multiple disciplines in dementia care and research, including medical, neuropsychology and nursing specialties, to focus on defining evidence-based multidisciplinary consensus guidelines for all practicing clinicians in the U.S.
The Community Engagement Alliance (CEAL) is made up of 21 states, whose mission is to educate and reduce misinformation in local communities that have been hit hardest by COVID-19 through community-focused research and outreach. As a participating member of the alliance, Arizona receives grant funding from the National Institutes of Health (NIH) to support the alliance’s initiative of increasing COVID-19 awareness, education and prevention strategies to areas disproportionately impacted by the disease.
With an urgent focus on mitigating the development and spread of COVID-19 to aid in ending the pandemic, Banner Health and The University of Arizona have formed the COVID-19 Research Oversight Committee. The committee is rapidly developing and executing strategies to leverage their current systems and expertise to create an environment of inclusiveness for hard-hit communities, encourage preventive measures and leverage the current systems and expertise to position Arizona for highly impactful research opportunities.
Since 2010, Banner Sun Health Research Institute has participated in a breakthrough program called the Parkinson’s Progression Markers Initiative, sponsored by the Michael J. Fox Foundation. This effort aims to identify biomarkers that could lead to Parkinson’s disease and designed to leverage the wealth of clinical and neuropathological samples from the Brain and Body Donation Program (BBDP). This international research undertaking continues multiple industry partners and clinical sites.
Contact Banner Research to learn more about our collaborations and partnerships.